Results 71 to 80 of about 1,163 (152)

TOP-ID: a Delphi technique-guided development of a prescription and deprescription tool for adults with intellectual disabilities

open access: yesBMJ Open, 2020
Objectives Adults with an intellectual disability (AWID) are often polymedicated because of somatic and psychiatric health problems. Besides, they may display challenging behaviours, leading to off-label prescription of psychotropic drugs, without ...
Sophie Lonchampt   +5 more
doaj   +1 more source

Development of a stepwise tool to aide primary health care professionals in the process of deprescribing in older persons [PDF]

open access: yes, 2020
Funding: The deprescribing tool was supported by Colciencias contract (110177758303 CT-792-2018) and Doctoral Fellowship Program 647-2015The aim of this study was to develop and validate a stepwise tool to aid primary health care professionals in the ...
Eslava-Schmalbach, Javier   +4 more
core   +1 more source

Increasing Prevalence of Long‐Term Antidepressant Use in Australia: A Retrospective Observational Study

open access: yesPharmacoepidemiology and Drug Safety, Volume 34, Issue 11, November 2025.
ABSTRACT Background Long‐term antidepressant use may reduce the risk–benefit profile due to the increased likelihood of withdrawal symptoms and higher incidence of side effects. This epidemiological study investigates historical trends in long‐term antidepressant use, which was defined as maintaining continuous antidepressant use for at least 365 days,
R. A. D. L. M. K. Ranwala   +3 more
wiley   +1 more source

Exploration of Perceptions of Deprescribing Practices Among Doctors in a Low‐ and Middle‐Income Country: A Mixed‐Methods Study

open access: yesBasic &Clinical Pharmacology &Toxicology, Volume 137, Issue 5, November 2025.
ABSTRACT With the increasing prevalence of potentially inappropriate medications in low‐ and middle‐income countries (LMICs) like Nepal, the role of deprescribing is ever important. However, evidence on how Nepalese doctors perceive deprescribing in their practice is lacking.
Anjan Khadka   +4 more
wiley   +1 more source

Deprescription as a tool of pharmaceutical care for the elderly

open access: yesRevista Brasileira de Farmácia Hospitalar e Serviços de Saúde, 2018
Maria Cristina Werlang
doaj   +2 more sources

Deprescribing Anticholinergic Medications in Hospitalised Older Adults: A Systematic Review

open access: yesBasic &Clinical Pharmacology &Toxicology, Volume 137, Issue 4, October 2025.
ABSTRACT Background Anticholinergic medication use is increasing, particularly among older adults due to polypharmacy and comorbidities. High anticholinergic burden is linked to adverse outcomes such as reduced mobility and increased dementia risk. Acute hospital stays may offer an opportunity to address this often‐overlooked issue. Aims To examine the
Rhianna Griffiths   +5 more
wiley   +1 more source

La ville à travers ses mots

open access: yes, 1996
Manuscrit version auteur, transmis par Christian Topalov. En ligne non OAI http://www.unesco.org/most/p2art.htmMis en ligne avec l'autorisation des auteursJe remercie chaleureusement Jean-Charles Depaule, directeur du LAU (UPR34 CNRS) depuis janvier 2004,
Depaule, Jean-Charles   +1 more
core   +2 more sources

Opioid Monitoring in Clinical Settings: Strategies and Implications of Tailored Approaches for Therapy [PDF]

open access: yes
This review emphasises the importance of opioid monitoring in clinical practice and advocates for a personalised approach based on pharmacogenetics. Beyond effectively managing pain, meticulous oversight is required to address concerns about side effects,
Barroso, Mário   +6 more
core   +3 more sources

Deprescribing NSAIDs: The Potential Role of Community Pharmacists

open access: yesPharmacy
Non-steroidal anti-inflammatory drugs (NSAIDs) are largely used for controlling various pain conditions and are widely available in community pharmacies, with and without prescription. Despite their effectiveness, NSAIDs can pose significant risks due to
Delsher Amedi, Parisa Gazerani
doaj   +1 more source

Insights Into Pharmacist‐Led Deprescribing of Benzodiazepines and Related Drugs: A Qualitative Study With Physicians and Pharmacists

open access: yesBasic &Clinical Pharmacology &Toxicology, Volume 137, Issue 4, October 2025.
ABSTRACT While deprescribing benzodiazepines and related drugs (BZRDs) is crucial for preventing prolonged use and their associated adverse effects, it presents challenges from a healthcare perspective, because of limited resources and time. Recently, a pharmacist‐led deprescribing of BZRDs in the treatment of insomnia was introduced in Helsinki's ...
Miro Korppas   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy